Podophyllin, a crude plant extract with low efficacy, high toxicity, and a serious mutagenicity profile does not comply with the WHO guidelines for plant derived treatments and should be removed from clinical treatment protocols. Home treatment with pharmaceutical products based on podophyllotoxin-the purified, standardised active antiwart ingredient of podophyllin-represents safe and effective first line therapy for patients with anogenital warts.
No takes yet. Share an insight, caveat, or question.
Geo von Krogh (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: